Negotiators struggle to find benefits for public health in TTIP

More than a year after the launch of the Trans-Atlantic Trade and Investment Partnership (TTIP) talks, negotiators from both sides of the Atlantic still struggle to prove the positive impact of the potential deal, on public health. 

TTIP has been criticised many times by health NGOs and campaigners for a lack of transparency, as well as for watering down health and consumer legislation, due to the dichotomy between public health and economic interest.

Speaking at the European Public Health Alliance's (EPHA) annual conference in Brussels (5 September) David Taylor, professor of Pharmaceutical and Public Health Policy at the University College London, said that there have been worries that via TTIP, the EU will move closer to the US on the precautionary principle.

Read full article here